Founder & CEO
Carey Turnbull has over a decade of experience in early-stage drug development on behalf of half a dozen companies variously as an investor, founder, and CEO. Early philanthropic donors supporting psychedelic science and research, Carey and Claudia Turnbull have been deeply involved in the development of better treatment options for those suffering from psychiatric and neurological disorders.
In addition to his roles as Founder and CEO of B. More, Ceruvia Lifesciences and Freedom to Operate, Carey is the chair of the advisory board to NYU’s Center for Psychedelic Medicine and a board member of the Heffter Research Institute.